View our free, on-demand webinar series to learn about the Oncomine Comprehensive Assay Plus

Comprehensive genomic profiling (CGP) is advancing precision oncology research through simultaneous analysis of multiple biomarkers in a single next-generation sequencing (NGS) assay. Some on-market hybrid-capture NGS assays prevent >57% of clinical research samples from being eligible for testing due to high sample input requirements and other technical limitations. In this webinar series, our speakers will discuss how the Ion Torrent Oncomine Comprehensive Assay Plus eliminates these limitations. They also shared their evaluation of the Oncomine Comprehensive Assay Plus for detection of multi-gene biomarkers, including TMB, MSI, fusion detection as well as homologous recombination repair deficiency (HRD).

Webinar 1:

Topic: Clinical research on genomic profiling with Comprehensive Plus
Speaker: Dr. Ines Raineri, Institute for Surgical Pathology, University Hospital and University of Zurich, Switzerland

Webinar 2:

Topic: Comprehensive Genome Profiling using the Oncomine Comprehensive Assay Plus
Speaker: Dr. Philip Martin Jermann, Director Molecular Assay Development, University Hospital Basel

Webinar 3:

Topic: Multicentric study to evaluate in-house solution for CGP
Speaker: Dr. Massimo Barberis, Director of Histopathology and Molecular Diagnostics Unit, European Institute of Oncology, Milan, Italy

Webinar 4:

Topic: Comprehensive Genomic Profiling for Homologous Recombination Repair Deficiency (HRD) Assessment
Speaker: Dr. Andreas Jung, Professor of Molecular Pathology, University of Munich

(*Indicates a mandatory field)